BioMedReports.com Articles

Categories

 



Active Stocks: AbbVie, Digirad Corp, ZIOPHARM Oncology, Aegerion Pharmaceuticals, Sarepta Therapeutics
Written by David Fowler   
Friday, 31 October 2014 15:48

U.S. stocks surged Friday, with the Dow hitting an intraday record, joining a rally in Asian and European shares that was spurred by the

Bank of Japan’s decision to unexpectedly expand its stimulus measures.

Read more...
 
Active Stocks: pSivida, Galena Biopharma, Cytokinetics, Epizyme, Alexza Pharmaceuticals
Written by Josh Gee   
Monday, 27 October 2014 16:03

Stocks wavered around the

Error. Page cannot be displayed. Please contact your service provider for more details. (1)

unchanged mark in afternoon trade Monday, as investors paused following the biggest weekly gains for major indexes in more than a year.
Read more...
 
Active Stocks: Amgen, Alkermes, Nanosphere, Biogen Idec, Regulus Therapeutics
Written by Josh Gee   
Wednesday, 22 October 2014 15:39

U.S. stocks turned lower in afternoon trading on Wednesday, with major indexes erasing earlier gains as a shooting at the Canadian parliament unnerved investors and Boeing and Biogen sold off following results.

Read more...
 
Active Stocks: Advaxis, DexCom, Cytokinetics, Valeant Pharmaceuticals, New Link Genetics
Written by Josh Gee   
Monday, 20 October 2014 14:38

U.S. stocks moved mostly higher Monday following a turbulent week. IBM fell sharply after reporting results that missed investors' expectations, pulling the Dow Jones industrial average lower.

Read more...
 
Active Stocks: Merck & Co, OncoGenex Pharmaceuticals, Ibio Inc, Orasure, AbbVie Inc
Written by Marilyn Mullen   
Thursday, 16 October 2014 17:31

U.S. stocks returned to the red Thursday afternoon, after clawing back from sharp early losses in a day of seesaw trading.

Read more...
 
Active Stocks: Aratana Therapeutics, Protalix BioTherapeutics, Cellceutix Corp, Sharps Compliance, Alnylam
Written by David Fowler   
Monday, 13 October 2014 18:20

U.S. stocks slumped, with the Standard & Poor’s 500 Index falling below its 200-day average, as investors weighed prospects for Federal Reserve interest rate increases and slowing global economic growth.

Read more...
 
<< Start < Prev 1 2 Next > End >>

Page 1 of 2
BMR:1